Concepedia
Statistics
Publications
4
Citations
58
H-Index
Active since
2019
Affiliations
Brigham and Women's Hospital(Current)
University of Würzburg
Harvard University
Karol Nawalaniec is an author at Brigham and Women's Hospital specializing in pathology, oncology, and medicine.
Top concepts
MedicineOncologyPathologyImmunologyCell BiologyImmunotherapyTumor BiologyCancer BiologyCancer ResearchColorectal Cancer
Publications per year
2019–2022
Expression of Tumor-mediated CD137 ligand in human colon cancer indicates dual signaling effects
Tanja Grimmig, Martin Gasser, Romana Moench et al. · OncoImmunology · 2019 · 17 citations · Full text
Immunology, Pathology, High Cd137l Expression +16
PDE4D targeting enhances anti-tumor effects of sorafenib in clear cell renal cell carcinoma and attenuates MAPK/ERK signaling in a CRAF-dependent manner
Minghua Cao, Karol Nawalaniec, Amrendra K. Ajay et al. · Translational Oncology · 2022 · 17 citations · Full text
Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer
Romana Moench, Martin Gasser, Karol Nawalaniec et al. · Oncotarget · 2022 · 14 citations · Full text
KMP01D Demonstrates Beneficial Anti-inflammatory Effects on Immune Cells: An ex vivo Preclinical Study of Patients With Colorectal Cancer
Martin Gasser, R. Lissner, Karol Nawalaniec et al. · Frontiers in Immunology · 2020 · 10 citations · Full text
1–4 of 4